tga bpc 157 approval status The hype around a new class of injectable drugs is in overdrive, but they have yet to be properly tested. Read the full story from Kishor Napier-Raman at the link in bio., Photo: Oscar Colman RACGP - TGA issues warning
Description
Small needle, big results Subcutaneous injections mean smaller needles, easier dosing and less painful than traditional intramuscular injections
Oral BPC-157 is most effective for gut-related conditions like ulcers, IBS, and Crohns
Modern manufacturing techniques have improved the ability to produce complex peptide structures with greater consistency
IQR, 0% to 0.96%), and Anaerococcus (median, 0.24%
